Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL705909 | 0.77 | MAPK1 (0.39) | MAPK1CA4ALDH1A1ALOX15ESR1 | |
| SCHEMBL277279 | 0.73 | MAPK1 (0.36) | MAPK1CA4ALDH1A1ALOX15ESR1 | |
| SCHEMBL704188 | 0.73 | MAPK1 (0.36) | MAPK1CA4ALDH1A1ALOX15ESR1 | |
| SCHEMBL702695 | 0.73 | MAPK1 (0.36) | MAPK1CA4ALDH1A1ALOX15ESR1 | |
| SCHEMBL17835393 | 0.72 | CA4 (0.38) | MAPK1CA4ALDH1A1ESR1ESR2 | |
| SCHEMBL703364 | 0.72 | ESR1 (0.34) | MAPK1ALDH1A1ALOX15ESR1ESR2 | |
| SCHEMBL708032 | 0.72 | NR1H2 (0.36) | MAPK1ALDH1A1ALOX15ESR1ESR2 | |
| SCHEMBL18108221 | 0.72 | CA4 (0.38) | MAPK1CA4ALDH1A1ESR1ESR2 | |
| SCHEMBL18108065 | 0.72 | CA4 (0.38) | MAPK1CA4ALDH1A1ESR1ESR2 | |
| SCHEMBL1313821 | 0.71 | ESR1 (0.35) | MAPK1CA4ALDH1A1ALOX15ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113045803-A | Antioxidant modified plastic particles and application thereof | 界首市宏佳塑业有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-107214808-B | Composite wood and its manufacturing method | 浙江润格木业科技有限公司 | 2019-06-07 | — | — | CN | claimed |
| EP-1343766-B1 | CYCLIZATION PROCESS STEP IN THE MAKING OF QUINOLONES AND NAPHTHYRIDINES | PROCTER & GAMBLE (US) | 2005-07-27 | — | — | EP | claimed |
| EP-1532114-A2 | PROCESS FOR PREPARING QUINOLONE ANTIBIOTIC INTERMEDIATES | THE PROCTER & GAMBLE COMPANY (US) | 2005-05-25 | — | — | EP | claimed |
| US-6803469-B2 | CYCLIZING IN THE PRESENCE OF A SILYLATING AGENT | THE PROCTER & GAMBLE COMPANY | 2004-10-12 | — | — | US | claimed |
| US-20040063952-A1 | Process for preparing quinolone antibiotic intermediates | WARNER CHILCOTT COMPANY, LLC | 2004-04-01 | — | — | US | claimed |
| WO-2004013103-A2 | PROCESS FOR PREPARING QUINOLONE ANTIBIOTIC INTERMEDIATES | THE PROCTER & GAMBLE COMPANY (US) | 2004-02-12 | — | — | WO | claimed |
| EP-1343766-A1 | CYCLIZATION PROCESS STEP IN THE MAKING OF QUINOLONES AND NAPHTHYRIDINES | THE PROCTER & GAMBLE COMPANY (US) | 2003-09-17 | — | — | EP | claimed |
| WO-2002048113-A1 | CYCLIZATION PROCESS STEP IN THE MAKING OF QUINOLONES AND NAPHTHYRIDINES | THE PROCTER & GAMBLE COMPANY (US) | 2002-06-20 | — | — | WO | claimed |
| US-11807758-B2 | Siloxane polymer and method of producing siloxane polymer | JNC CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11572434-B2 | Curable composition, method for producing same, and article using same | DAIKIN INDUSTRIES, LTD. (JP) | 2023-02-07 | — | — | US | disclosed |
| US-20210238419-A1 | SILOXANE POLYMER AND METHOD OF PRODUCING SILOXANE POLYMER | JNC CORPORATION (JP) | 2021-08-05 | — | — | US | disclosed |
| CN-113045803-A | Antioxidant modified plastic particles and application thereof | 界首市宏佳塑业有限公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-113045803-A | Antioxidant modified plastic particles and application thereof | 界首市宏佳塑业有限公司 | 2021-06-29 | — | — | CN | disclosed |
| US-5703231-A | Process for making antimicrobial compounds | THE PROCTER & GAMBLE COMPANY (US) | 1997-12-30 | — | — | US | disclosed |
| EP-0775145-A1 | PROCESS FOR MAKING QUINOLONYL LACTAM ANTIMICROBIALS AND NOVEL INTERMEDIATE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| EP-0775114-A1 | PROCESS FOR MAKING ANTIMICROBIAL COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996004286-A9 | PROCESS FOR MAKING QUINOLONYL LACTAM ANTIMICROBIALS AND NOVEL INTERMEDIATE COMPOUNDS | — | 1997-05-22 | — | — | WO | disclosed |
| WO-1996004247-A1 | PROCESS FOR MAKING ANTIMICROBIAL COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1996-02-15 | — | — | WO | disclosed |
| WO-1996004286-A1 | PROCESS FOR MAKING QUINOLONYL LACTAM ANTIMICROBIALS AND NOVEL INTERMEDIATE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1996-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063952-A1 | Process for preparing quinolone antibiotic intermediates | QPCT, CCNT1, TOP1 | MAPK1 1045/4885CA4 1757/4885ALDH1A1 751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.